SCHEMBL6229249

SCHEMBL6229249

COc1ccc(C=O)cc1OCCc1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FDPS P14324 1/20 0.63
MAPT P10636 6/20 0.63
SMN1; SMN2 Q16637 4/20 0.63
NPSR1 Q6W5P4 2/20 0.63
LMNA P02545 2/20 0.63
HTT P42858 2/20 0.63
ALDH1A1 P00352 6/20 0.58
TSHR P16473 1/20 0.58
SIGMAR1 Q99720 6/20 0.57
CYP2C9 P11712 3/20 0.56
TTR P02766 2/20 0.56
NPC1 O15118 1/20 0.56
RAB9A P51151 1/20 0.56
HPGD P15428 4/20 0.54
CYP1A2 P05177 2/20 0.54
CYP2C19 P33261 2/20 0.54
CYP2D6 P10635 1/20 0.54
EBP Q15125 1/20 0.54
TMEM97 Q5BJF2 1/20 0.54
HSP90AA1 P07900 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31331562 0.94 FDPS (0.72) FDPSMAPTSMN1; SMN2NPSR1LMNA
SCHEMBL9078005 0.94 FDPS (0.72) FDPSMAPTSMN1; SMN2NPSR1LMNA
SCHEMBL7545268 0.92 MAPT (0.60) FDPSMAPTSMN1; SMN2NPSR1LMNA
SCHEMBL4576841 0.91 FDPS (0.57) FDPSMAPTSMN1; SMN2NPSR1LMNA
SCHEMBL6942920 0.91 MAPT (0.59) FDPSMAPTSMN1; SMN2NPSR1LMNA
SCHEMBL6228384 0.91 MAPT (0.59) FDPSMAPTSMN1; SMN2NPSR1LMNA
SCHEMBL6582635 0.87 FDPS (0.61) FDPSMAPTSMN1; SMN2NPSR1LMNA
SCHEMBL6949716 0.87 MAPT (0.55) FDPSMAPTSMN1; SMN2NPSR1LMNA
SCHEMBL6950497 0.87 MAPT (0.55) FDPSMAPTSMN1; SMN2NPSR1LMNA
SCHEMBL13620651 0.87 MAPT (0.57) FDPSMAPTSMN1; SMN2NPSR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0933366-B1 5-PHENYL-3-PYRIDAZINONE DERIVATIVES AND DRUG COMPOSITIONS CONTAINING THE SAME NIKKEN CHEMICALS CO LTD (JP) 2005-04-06 EP disclosed
EP-0928789-B1 6-PHENYLTETRAHYDRO-1,3-OXAZIN-2-ONE DERIVATIVES AND MEDICINAL COMPOSITIONS CONTAINING THE SAME NIKKEN CHEMICALS CO LTD (JP) 2004-09-29 EP disclosed
US-6265402-B1 ANTIINFLAMMATORY AGENTS NIKKEN CHEMICALS CO., LTD. (JP) 2001-07-24 US disclosed
US-6251897-B1 TREATING DERMATITIS, ASTHMA NIKKEN CHEMICALS CO., LTD (JP) 2001-06-26 US disclosed
US-6235739-B1 ANTIINFLAMMATORY AGENTS; ANTIHISTAMINES; SKIN DISORDERS NIKKEN CHEMICALS CO., LTD. (JP) 2001-05-22 US disclosed
EP-0870758-B1 OPTICALLY ACTIVE SUBSTITUTED PHENYLALKYLAMINE DERIVATIVES TAISHO PHARMACEUTICAL CO LTD (JP) 2001-02-21 EP disclosed
US-5990151-A SIGMA 1 RECEPTOR ANTAGOISTS; PSCHOLOGICAL DISORDERS; BRAIN DISORDERS; SCHIZOPHRENIA; ANTIDEPRESSANTS; ANXIOLYTIC AGENTS; ALZHEIMER'S DISEASE; COGNITION ACTIVATORS; HUNTINGTON'S DISEASE; DRUG ABUSE; SIDE EFFECT REDUCTION TAISHO PHARMACEUTICAL CO., LTD. (JP) 1999-11-23 US disclosed
EP-0933366-A1 5-PHENYL-3-PYRIDAZINONE DERIVATIVES AND DRUG COMPOSITIONS CONTAINING THE SAME Nikken Chemicals Company, Limited (JP) 1999-08-04 EP disclosed
EP-0928789-A1 6-PHENYLTETRAHYDRO-1,3-OXAZIN-2-ONE DERIVATIVES AND MEDICINAL COMPOSITIONS CONTAINING THE SAME Nikken Chemicals Company, Limited (JP) 1999-07-14 EP disclosed
EP-0924204-A1 2-PHENYLMORPHOLIN-5-ONE DERIVATIVES AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME Nikken Chemicals Company, Limited (JP) 1999-06-23 EP disclosed
EP-0641766-B1 ALKOXYPHENYLALKYLAMINE DERIVATIVE TAISHO PHARMACEUTICAL CO LTD (JP) 1998-11-11 EP disclosed
EP-0870758-A1 OPTICALLY ACTIVE SUBSTITUTED PHENYLALKYLAMINE DERIVATIVES TAISHO PHARMACEUTICAL CO. LTD (JP) 1998-10-14 EP disclosed
WO-1997003967-A1 SUBSTITUTED AROMATIC COMPOUNDS AND THEIR PHARMACEUTICAL USE RHONE-POULENC RORER LIMITED (GB) 1997-02-06 WO disclosed
US-5495046-A PSYCHOLOGICAL DISORDERS TAISHO PHARMACEUTICAL CO., LTD. (JP) 1996-02-27 US disclosed
EP-0641766-A1 ALKOXYPHENYLALKYLAMINE DERIVATIVE TAISHO PHARMACEUTICAL CO. LTD (JP) 1995-03-08 EP disclosed